XML 47 R32.htm IDEA: XBRL DOCUMENT v3.20.4
Cash and Marketable Securities (Tables)
12 Months Ended
Dec. 31, 2020
Cash and Cash Equivalents [Abstract]  
Schedule of Investment Components
The components of our investments as of December 31, 2020 are as follows (in millions):
 Cash & Cash EquivalentsRestricted CashRestricted Marketable SecuritiesTotal
Cash$224.0 $86.9 $— $310.9 
Equity securities— — 72.6 72.6 
Total
$224.0 $86.9 $72.6 $383.5 
The components of our investments as of December 31, 2019 are as follows (in millions):
 Cash & Cash EquivalentsRestricted CashRestricted Marketable SecuritiesTotal
Cash$94.8 $64.8 $— $159.6 
Equity securities— — 63.5 63.5 
Debt securities— — 12.6 12.6 
Total
$94.8 $64.8 $76.1 $235.7 
Schedule of Restricted Cash
As of December 31, 2020 and 2019, Restricted cash consisted of the following (in millions):
 As of December 31,
 20202019
Current:
Affiliate cash
$17.5 $16.0 
Self-insured captive funds
47.9 41.4 
65.4 57.4 
Noncurrent:
Self-insured captive funds
21.5 7.4 
Total restricted cash
$86.9 $64.8 
Available-for-sale Securities Cost to Fair Value Reconciliation
A summary of our available-for-sale marketable securities as of December 31, 2019 is as follows (in millions):
 CostGross Unrealized GainsGross Unrealized LossesFair Value
Debt securities$12.6 $— $— $12.6 
Investment Information Related to Restricted Marketable Securities
Investing information related to our available-for-sale marketable securities is as follows (in millions):
 For the Year Ended December 31,
 202020192018
Proceeds from sales and maturities of available-for-sale marketable securities$12.6 $6.4 $—